Notice Pursuant to the National Cooperative Research and Production Act of 1993-Pistoia Alliance, Inc., 53493-53494 [2022-18817]

Download as PDF Federal Register / Vol. 87, No. 168 / Wednesday, August 31, 2022 / Notices Director, Policy and Planning Staff, Office of the Chief Information Officer, Justice Management Division, United States Department of Justice, Two Constitution Square, 145 N Street NE, 3E–206, Washington, DC 20530. Dated: August 25, 2022. Robert Houser, Assistant Director, Policy and Planning Staff, Office of the Chief Officer, U.S. Department of Justice. [FR Doc. 2022–18758 Filed 8–30–22; 8:45 am] BILLING CODE 4410–FY–P DEPARTMENT OF JUSTICE Bureau of Alcohol, Tobacco, Firearms and Explosives [OMB Number 1140–0006] Agency Information Collection Activities; Proposed eCollection of eComments Requested; Application and Permit for Importation of Firearms, Ammunition and Defense Articles— ATF Form 6—Part II (5330.3B) Bureau of Alcohol, Tobacco, Firearms and Explosives, Department of Justice. ACTION: 30-Day notice. AGENCY: The Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF), Department of Justice (DOJ) will submit the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed collection OMB 1140– 0006 (Application and Permit for Importation of Firearms, Ammunition and Defense Articles—ATF Form 6— Part II (5330.3B)) is being revised to include a Continuation Sheet, so that additional firearms can be listed on the same permit application. The proposed information collection is also being published to obtain comments from the public and affected agencies. DATES: Comments are encouraged and will be accepted for an additional 30 days until September 30, 2022. ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning lotter on DSK11XQN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 16:59 Aug 30, 2022 Jkt 256001 the proposed collection of information are encouraged. Your comments should address one or more of the following four points: • Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; • Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; • Evaluate whether and, if so, how the quality, utility, and clarity of the information to be collected can be enhanced; and • Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of This Information Collection 1. Type of Information Collection: Revision of a Currently Approved Collection. 2. The Title of the Form/Collection: Application and Permit for Importation of Firearms, Ammunition and Defense Articles. 3. The agency form number, if any, and the applicable component of the Department sponsoring the collection: Form number: ATF Form 6—Part II (5330.3B). Sponsor: Bureau of Alcohol, Tobacco, Firearms and Explosives, U.S. Department of Justice. 4. Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Business or other for-profit. Other: Individuals or households. Abstract: The information collected on the Application and Permit for Importation of Firearms, Ammunition and Defense Articles—ATF Form 6— Part II (5330.3B) is used to determine if the article(s) described in the application qualifies for importation by the importer, and also serves as authorization for the importer. 5. An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: An estimated 400 respondents will respond to this collection once annually, and it will take each respondent approximately 30 minutes to complete their responses. 6. An estimate of the total public burden (in hours) associated with the PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 53493 collection: The estimated annual public burden associated with this collection is 200 hours, which is equal to 400 (total respondents) * 1 (# of response per respondent) * .5 (30 minutes or the time taken to prepare each response). If additional information is required contact: Robert Houser, Assistant Director, Policy and Planning Staff, Office of the Chief Information Officer, Justice Management Division, United States Department of Justice, Two Constitution Square, 145 N Street NE, 3E–206, Washington, DC 20530. Dated: August 25, 2022. Robert Houser, Assistant Director, Policy and Planning Staff, Office of the Chief Information Officer, U.S. Department of Justice. [FR Doc. 2022–18755 Filed 8–30–22; 8:45 am] BILLING CODE 4410–FY–P DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Pistoia Alliance, Inc. Notice is hereby given that, on May 16, 2022, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (the ‘‘Act’’), Pistoia Alliance, Inc. filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Medable, Palo Alto, CA; Prism Analytic Technologies Inc, Cambridge, MA; Intelligencia, New York, NY; uncountable Inc, San Francisco, CA; Terra Quantum AG, Rorschach, SWITZERLAND; Chiesi Farmaceutici SpA, Parma, ITALY; Dynaccurate SARL, LUXEMBOURG; Whitespace SARL, Vernier, SWITZERLAND; GNS Healthcare Inc, Somerville, MA; and Gliff Ltd., Aykley Heads, UNITED KINGDOM have been added as parties to this venture. Also, BioSymmetrics, Huntingdon, NY; Nanome, San Diego, CA; and Nutanix BV, Hoofdorp, NETHERLANDS have withdrawn as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and Pistoia Alliance, Inc. intends to file additional E:\FR\FM\31AUN1.SGM 31AUN1 53494 Federal Register / Vol. 87, No. 168 / Wednesday, August 31, 2022 / Notices written notifications disclosing all changes in membership. On May 28, 2009, Pistoia Alliance, Inc. filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to section 6(b) of the Act on July 15, 2009 (74 FR 34364). The last notification was filed with the Department on February 28, 2022. A corrected notice was published in the Federal Register pursuant to section 6(b) of the Act on July 20, 2022 (87 FR 43298). Suzanne Morris, Chief, Premerger and Division Statistics, Antitrust Division. [FR Doc. 2022–18817 Filed 8–30–22; 8:45 am] BILLING CODE 4410–11–P need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on July 7, 2022, Experic LLC, 2 Clarke Drive, Cranbury, New Jersey 08512–3619, applied to be registered as an importer of the following basic class(es) of controlled substance(s): DEPARTMENT OF JUSTICE Controlled substance Drug Enforcement Administration Marihuana Extract .... Marihuana ................. Tetrahydrocannabinols. Psilocybin ................. 5-Methoxy-N–NDimethyltryptamine. Psilocyn .................... Nabilone ................... [Docket No. DEA–1072] Importer of Controlled Substances Application: Experic LLC Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Experic LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before September 30, 2022. Such persons may also file a written request for a hearing on the application on or before September 30, 2022. ADDRESSES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no lotter on DSK11XQN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 16:59 Aug 30, 2022 Jkt 256001 Drug code Schedule 7350 7360 7370 I I I 7437 7431 I I 7438 7379 I II The company plans to import drug code 7437 (Psilocybin) and Psilocyn (7438) as bulk powder and Marihuana Extract (7350), Marihuana (7360) Tetrahydrocannabinols (7370) and Nabilone (7379) as finished dosage units for research and clinical trial purposes. No other activity for this drug code is authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale. Kristi O’Malley, Assistant Administrator. [FR Doc. 2022–18744 Filed 8–30–22; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–372] Exempt Chemical Preparations Under the Controlled Substances Act Drug Enforcement Administration, Department of Justice. AGENCY: PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 Order with opportunity for comment. ACTION: The applications for exempt chemical preparations received by the Drug Enforcement Administration (DEA) between August 30, 2021, and March 31, 2022, as listed below, were accepted for filing and have been approved or denied as indicated. DATES: Interested persons may file written comments on this order in accordance with 21 CFR 1308.23(e). Electronic comments must be submitted, and written comments must be postmarked, on or before October 31, 2022. Commenters should be aware that the electronic Federal Docket Management System will not accept comments after 11:59 p.m. eastern time on the last day of the comment period. ADDRESSES: To ensure proper handling of comments, please reference ‘‘Docket No. DEA–372’’ on all correspondence, including any attachments. Electronic comments: DEA encourages that all comments be submitted through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or to attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon completion of your submission you will receive a Comment Tracking Number for your comment. Please be aware that submitted comments are not instantaneously available for public view on Regulations.gov. If you have received a comment tracking number, your comment has been successfully submitted and there is no need to resubmit the same comment. Paper comments: Paper comments that duplicate the electronic submission are not necessary and are discouraged. Should you wish to mail a comment in lieu of an electronic comment, it should be sent via regular or express mail to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. FOR FURTHER INFORMATION CONTACT: Terrence L. Boos, Ph.D., Diversion Control Division, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (571) 362–8201. SUPPLEMENTARY INFORMATION: SUMMARY: Posting of Public Comments Please note that all comments received are considered part of the public record and made available for public inspection online at https:// E:\FR\FM\31AUN1.SGM 31AUN1

Agencies

[Federal Register Volume 87, Number 168 (Wednesday, August 31, 2022)]
[Notices]
[Pages 53493-53494]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-18817]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Pistoia Alliance, Inc.

    Notice is hereby given that, on May 16, 2022, pursuant to section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (the ``Act''), Pistoia Alliance, Inc. filed 
written notifications simultaneously with the Attorney General and the 
Federal Trade Commission disclosing changes in its membership. The 
notifications were filed for the purpose of extending the Act's 
provisions limiting the recovery of antitrust plaintiffs to actual 
damages under specified circumstances. Specifically, Medable, Palo 
Alto, CA; Prism Analytic Technologies Inc, Cambridge, MA; 
Intelligencia, New York, NY; uncountable Inc, San Francisco, CA; Terra 
Quantum AG, Rorschach, SWITZERLAND; Chiesi Farmaceutici SpA, Parma, 
ITALY; Dynaccurate SARL, LUXEMBOURG; Whitespace SARL, Vernier, 
SWITZERLAND; GNS Healthcare Inc, Somerville, MA; and Gliff Ltd., Aykley 
Heads, UNITED KINGDOM have been added as parties to this venture.
    Also, BioSymmetrics, Huntingdon, NY; Nanome, San Diego, CA; and 
Nutanix BV, Hoofdorp, NETHERLANDS have withdrawn as parties to this 
venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and Pistoia Alliance, Inc. intends to 
file additional

[[Page 53494]]

written notifications disclosing all changes in membership.
    On May 28, 2009, Pistoia Alliance, Inc. filed its original 
notification pursuant to section 6(a) of the Act. The Department of 
Justice published a notice in the Federal Register pursuant to section 
6(b) of the Act on July 15, 2009 (74 FR 34364).
    The last notification was filed with the Department on February 28, 
2022. A corrected notice was published in the Federal Register pursuant 
to section 6(b) of the Act on July 20, 2022 (87 FR 43298).

Suzanne Morris,
Chief, Premerger and Division Statistics, Antitrust Division.
[FR Doc. 2022-18817 Filed 8-30-22; 8:45 am]
BILLING CODE 4410-11-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.